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MINI-SYMPOSIUM ON EMERGING TECHNIQUES FOR LUNG CANCER STAGING
Mediastinoscopic Ultrasonography
Martin Hu¨rtgen, MD, Michael Wolf, MD, and Biruta Witte, MD
Objectives: Pretherapeutic T4 staging of centrally located lung
cancer is crucial for the treatment strategy, but non-invasive imaging
techniques are of low accuracy. We have developed the new imag-
ing technique of intraoperative mediastinoscopic ultrasound (MUS)
to predict technical resectability in tumors staged cT4 based on
computed tomographic scanning.
Methods: Intraoperatively, a sterilizable fingertip ultrasound probe
is introduced and guided through the video mediastinoscope with a
modified grasper during staging mediastinoscopy. The position of
the probe in front of the tracheobronchial tree and in direct contact
with the vena cava and pulmonary artery reduces air interference.
We reviewed the results for 24 patients with tumors staged
cT4 between July 2002 and January 2006. For 18, the prediction of
MUS concerning resectability could be compared with intraopera-
tive findings at the time of thoracotomy.
Results: MUS visualizes all central vessels and their relation to the
tumor with high accuracy. The pulmonary artery and pulmonary
veins are displayed not only in their central parts but also in their
interlobar branches.
Of the 24 patients, 18 proceeded to thoracotomy after con-
clusive MUS and had tumors proved to be technically resectable in
accordance with prediction by MUS. Comparison of cT (computed
tomographic scan), cT (MUS) and pT revealed that T stages defined
by MUS accurately predict pathologic T stages.
Conclusion: MUS allows investigators to assess infiltration of the
great vessels and the mediastinum, especially in right-sided tumors.
MUS will supplement endoscopic ultrasound-guided fine needle
aspiration for the right upper mediastinum in staging of centrally
located tumors.
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Exploratory thoracotomy for technical or oncological unre-sectability of a tumor should be avoided. Induction ther-
apy is preferred for patients with N2 disease or with T4
tumors. Combining PET, systematic video-assisted mediasti-
noscopic lymphadenectomy,1–3 and endoscopic ultrasound-
guided fine needle aspiration (transesophageal: EUS, trans-
bronchial: EBUS) positive mediastinal lymph nodes can be
detected with specificity and sensitivity of nearly 100 %.
However, there is still no imaging method to allow
verification of T4 stage of central tumors. Computed tomog-
raphy (CT) and magnetic resonance imaging (MRI) do not
offer a satisfying level of sensitivity and specificity for
staging of potential T4 lesions, both having a tendency for
overstaging.4,5 Overstaging may exclude patients with oper-
able tumors from curative surgical resection, whereas other
patients undergo unnecessary induction treatment. Further,
without precise pretreatment staging, the rate of down-stag-
ing reported in neo-adjuvant therapy studies remains ques-
tionable. EUS is helpful in detecting tumor infiltration of the
lower mediastinum and heart.6–8 However, it is impossible to
see infiltration of vena cava, vena azygos, aortic arch, and
important sections of the pulmonary artery because of air in
the tracheobronchial tree (Figure 1).
We developed intraoperative mediastinoscopic ultra-
sonography (MUS)9 to avoid this air interference. (Figure 2).
METHODS
MUS is integrated with staging mediastinoscopy in one
operation to confirm or rule out infiltration of mediastinum,
cardiac structures, or vessels using sonomorphological crite-
ria (borderlines of vessel wall, mediastinal pleura and peri-
cardium, real-time pulsating movement of the vessels, and
respiratory movement of the lung, total reflection of ultra-
sound by air-filled lung parenchyma) and to judge technical
resectability on this basis. All tumors with no evidence of
central infiltration were denominated T2.
We use a video mediastinoscope (Richard Wolf GmbH,
Knittlingen, Germany) and the Hitachi EUB-525 ultrasound
system (Hitachi Ultrasound GmbH, Wiesbaden, Germany).
The 5- to 10-MHz curved fingertip intraoperative probe
(F 334; Hitachi Ultrasound GmbH) is introduced with the
help of a modified endoscopic grasper (Richard Wolf
GmbH). Position and orientation of the ultrasound transducer
are controlled by the video-mediastinoscopic image and the
position of the grasper’s handle. On its way down to a
position caudally to the bifurcation of the trachea, the trans-
ducer stays in direct contact with vena cava, vena azygos,
aorta, pulmonary artery, and finally the heart.
Katholisches Klinikum, Marienhof/St. Josef gGmbH, Bru¨derhaus, Abt. Tho-
raxchirurgie, Koblenz, Germany.
Disclosure: The Richard Wolf Company and Hitachi have supported the
development of MUS. Martin Hu¨rtgen works in cooperation with the
Richard Wolf Company in the development of instruments for minimally
invasive thoracic surgery and video mediastinoscopy.
Address for correspondence: Martin Hu¨rtgen, Katholisches Klinikum,
Marienhof/St. Josef gGmbH, Bru¨derhaus-; Abt. Thoraxchirurgie, Kardi-
nal-Krementz-Str. 1-5, D-56073 Koblenz, Germany. E-mail m.huertgen@
kk-koblenz.de
Copyright © 2007 by the International Association for the Study of Lung
Cancer
ISSN: 1556-0864/07/0204-0362
Journal of Thoracic Oncology • Volume 2, Number 4, April 2007362
MUS may be performed before or after the nodal
dissection but is usually the last operative step, although there
may be some artifacts from air bubbles and fatty detritus in
the mediastinum. With all the nodes resected and the ana-
tomical landmarks identified and exposed, it is easier to
control the position of the ultrasound probe. In bulky disease,
it may be advantageous to begin the operation with MUS.
Ultrasound information about the diameter of the diseased
nodes and their relation to the vessels reduces the risk of
major bleeding when taking the biopsy.
RESULTS
From July 2002 to December 2005, we identified 24
patients presenting with centrally located pulmonary carci-
noma staged cT4 based on a CT scan. The CT interpretation
was adopted from the contributing radiologists according to
the medical records. We examined 18 men and 6 women with
an average age of 63 years (range, 48–79 years). Histological
types of the tumors comprised 22 non-small cell lung cancer
and 2 small cell lung cancer. There were 18 tumors on the
right side and 6 on the left side.
No complications occurred during the examinations.
MUS and the corresponding documentation of the findings
prolonged the operation time by approximately 10 minutes.
Of the 24 patients, 3 had N2- or N3-positive lymph
nodes. These patients proceeded to chemotherapy or chemo-
radiation even though their tumors were judged to be resect-
able based on the MUS results.
We did not proceed to thoracotomy in the one patient
for whom MUS examination confirmed obvious irresectable
T4 stage in accordance with a CT scan. Ultrasound exami-
nation showed infiltration of the pulmonary artery adjacent to
the pulmonary trunk in accordance with a CT scan for Patient
7. Therefore, this patient was excluded from surgery and
received chemoradiation therapy. Consequently, we cannot
comment on the positive predictive value of MUS for pT4.
For Patients 6 and 24, with left-sided central tumors,
infiltration of central vessels and mediastinum could not be
judged conclusively by MUS because of artifacts resulting
from the air-filled left main bronchus. By the time of thora-
cotomy, their tumors proved resectable.
Conclusive assessment of central infiltration on the
basis of MUS could be correlated with intraoperative
findings for the remaining 18 patients. For four of these
patients (Patients 9, 12, 14, and 17), unexpected intraop-
erative functional or oncological inoperability precluded
resection, but exploration of the central structures con-
firmed technical resectability as predicted by MUS. The
remaining 14 patients proceeded to R0 resection. For these
14 patients, full data records are available, and T stage
after CT scans, MUS evaluation, and pathological exami-
nation were compared (Figure 3). One patient whose tumor
was predicted cT2 by MUS had to have the tumor staged
pT3 for endobronchial tumor extension; thus, the tumor
was formally understaged by MUS but was nonetheless
correctly judged resectable.
Discussion
Although the distinction of tissue borders by CT re-
quires a considerable difference in x-ray absorption and a
FIGURE 1. Air in the trachea obstructs the view of trans-
esophageal endosonography. Using mediastinoscopic ultra-
sonography, the ultrasound probe is located in front of the
trachea, making the shadowed area visible.
FIGURE 2. The spatulas of the video-mediastinoscope are
spread wide, and the fingertip ultrasound probe is inserted
using a modified grasper.
FIGURE 3. Stage migration. Comparison between clinical
(computed tomographic scan, mediastinoscopic ultrasound)
and pathological T stages.
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certain thickness of the tissue layers, the resolution offered by
ultrasound is based on its ability to detect tissue borders
through different sound conduction, quasi-independent of the
thickness of the tissue layers. Mediastinal pleura and pericar-
dium may help to rule out tumor invasion using ultrasound,
although they are too thin to be detected by CT (Figure 4).
Preserved pulsating movements of the vessels and respiratory
movements of the lung, visible in the real-time mode of
ultrasound imaging, may help to rule out tumor invasion
while disturbing CT imaging.
However, ultrasound examination of the mediastinum
is limited by the interferences caused by the air-filled struc-
tures (tracheobronchial tree and lung). With MUS, those
structures of the upper mediastinum that are not accessible to
EUS can be inspected. Further MUS identifies tumor infil-
tration of more peripheral parts of the upper pulmonary vein
or artery as far as the interlobar branches.
Until now, we have had no experience with MUS for
restaging after induction treatment what may be another
valuable application for MUS. In pre-therapeutic staging,
MUS was highly accurate in prediction of pT stage with a
100% negative predictive value for pT4. MUS is a valu-
able supplement to EUS for exclusion or verification of
cT4 stage.
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FIGURE 4. Suspected infiltration of right brachiocephalic
vein in computed tomographic scan. Mediastinoscopic ultra-
sound shows preserved reflection line between tumor (TU)
and brachiocephalic vein (V) that ruled out infiltration and
confirmed pT2. A, Brachiocephalic artery.
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